Challenges in diagnosis and management of Langerhans Cell Histiocytosis in a 13-month-old child: a rare case report.

Autor:	Sedain G; Department of Neurosurgery, Institute of Medicine, Tribhuvan University Teaching Hospital., Khanal K; Department of Internal Medicine, Greencity Hospital Private Limited, Basundhara., Pandey A; Department of Pediatrics, Civil Service Hospital of Nepal, Minbhawan., Parajuli S; Department of Internal Medicine., Sherpa PL; Department of Internal Medicine, Horizon Hospital Private Limited, Sesmati., Adhikari S; Department of General Surgery, Kathmandu Medical College and Teaching Hospital, Sinamangal., Thakuri A; Department of Internal Medicine, Nepal Armed Police Force Hospital, Balambu., Kattel A; Department of Pathology, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Jazyk:	angličtina
Zdroj:	Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2024 Aug 06; Vol. 86 (9), pp. 5611-5617. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).
DOI:	10.1097/MS9.0000000000002430
Abstrakt:	Introduction: Langerhans Cell Histiocytosis is a rare condition characterized by the proliferation of abnormal Langerhans cells in the skin and mucosa. It is mostly seen in children between 1 and 3 years old. Although the skeleton accounts for 80% of infiltration and the skin accounts for 33%, it can affect other organs as well. Case Presentation: The authors report a case of a 13-month-old male with fever, rash, and nontender swelling in the frontal, temporal, and infraorbital regions. Imaging showed diffusion restriction in the frontal, left parietal, right sphenoid, right temporal bones, and right maxillary antrum. Biopsy and immunohistochemistry from the right maxilla confirmed the diagnosis. The patient was treated with vinblastine and prednisolone for 3 months, resulting in reduced swelling and no fever on follow-up. Discussion: Langerhans Cell Histiocytosis (LCH), formerly Histiocytosis X, has diverse clinical manifestations and is classified as localized or disseminated based on organ involvement. It is associated with viral infections, communication defects, and cytokine processes, with BRAF mutations and the MAPK/ERK pathway implicated. Diagnosis involves clinical, radiological, histological, and immunophenotypic methods, including identifying Birbeck granules in Langerin-positive cells. Treatment varies by disease extent, with vinblastine and prednisolone for children with multisystem disease and tailored approaches for adults. Conclusion: Despite atypical presentation, thorough evaluation confirmed Langerhans Cell Histiocytosis in a pediatric patient. This highlights the necessity of considering Langerhans Cell Histiocytosis in differential diagnoses for persistent cutaneous lesions and bony swellings. Prompt detection and timely action are essential for successful treatment and better results. Competing Interests: The authors declare that they have no financial conflict of interest with regard to the content of this report.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu